SMC021A

· Nordic Bioscience A/S

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SMC021A, covering 2007-06-14 to 2007-06-14. Get the full timeline:

Most recent: Clinical Trial Update: SMC021A - Absorption, Efficacy and Tolerance in Patients With Osteoarthritis. A Placebo-Controlled 14-Days Study [Phase 1]

See pricing